Chemring Group PLC

Chemring Group PLC

CMGMY
Chemring Group PLCUS flagOther OTC
6.36
USD
+0.02
- -
1.72BMarket Cap
Chemring Group PLC
CMGMY
(Other OTC)

Recent

price

6.36

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
0.59
3.42
3.35
2.14
1.83
1.71
1.83
1.1
1.06
1.2
1.43
1.4
1.43
1.68
1.79
1.84
Revenue per Share
0.07
0.35
0.07
-0.22
-0.25
- -
0.04
0.02
-0.38
0.08
0.12
0.15
0.17
0.02
0.14
0.18
Basic EPS, GAAP
0.03
0.18
0.25
0.16
0.11
0.04
0.18
0.06
0.05
0.06
0.12
0.16
0.16
0.11
0.05
-0.04
Free Cash Flow per Basic Share
0.02
0.11
0.14
0.07
0.05
0.04
- -
0.02
0.03
0.03
0.04
0.04
0.05
0.06
0.07
0.08
Dividend per Share
0.2
1.21
1.08
0.79
0.44
0.4
0.48
0.42
0.04
0.04
0.11
0.21
0.32
0.23
0.2
0.3
Book Value per Share
-0.1
0.08
0.09
0.21
0.28
0.27
0.62
0.66
0.44
0.52
0.62
0.71
0.91
0.89
0.84
0.81
Tangible Book Value per Share
1,008
212
221
221
221
221
261
279
280
280
281
282
281
282
273
271
Basic Weighted Avg Shares
597
724
740
472
403
377
477
307
297
335
402
393
401
473
488
498
Sales/Revenue/Turnover
19.88
13.95
5
-9.89
6.3
1.46
5.49
1.5
-5.35
9.34
11.5
12.81
12.32
9.61
11.59
14.75
Operating Margin (%)
31
44
41
45
40
37
40
36
31
29
29
25
22
22
24
27
Depreciation Expense
67
74
15
-48
-55
- -
11
7
-106
22
35
42
47
5
40
48
Net Income, GAAP
25.14
18.03
29.79
- -
- -
- -
18.75
- -
- -
13.48
19.86
14.96
7.31
14.51
19.88
21.27
Effective Tax Rate (%)
11.17
10.21
2.07
-10.23
-13.62
-0.11
2.33
2.15
-35.57
6.53
8.62
10.55
11.82
1.14
8.09
9.69
Profit Margin (%)
66
121
118
142
93
86
136
87
84
-9
57
46
68
42
100
130
Working Capital
298
266
265
261
156
161
121
62
91
8
61
30
25
20
53
104
LT Debt
323
475
434
384
300
291
413
401
294
306
330
353
418
378
356
382
Total Equity
15.2
10.79
3.21
- -
- -
- -
4.12
- -
- -
6.96
9.35
10.63
10.64
8.89
10.27
11.37
Return on Invested Capital (%)
18.25
14.53
4.53
- -
- -
- -
7.85
- -
- -
23.13
38.17
44.89
45.53
5.31
33.04
24.83
Return on Capital (%)
38.55
32.48
6.19
-23.43
-40.34
-0.43
10.46
5.48
-167.67
206.6
164.85
92.43
63.62
6.94
65.45
70.78
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.18%
3.48%
7.21%
Free Cash Flow
26.63%
-48.71%
-184.85%
Net Income, GAAP
-408.21%
119.74%
22.03%
Sales/Revenue/Turnover
4.32%
4.55%
1.88%
Total Cash Common Dividend
- -
16.05%
10.1%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
488
2025
- -
- -
- -
- -
498
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.14
2025
- -
- -
- -
- -
0.18
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.07
2025
- -
- -
- -
- -
0.08
2026
- -
- -
- -
- -
- -
Business
Chemring Group PLC is a United Kingdom-based defence technology company specializing in the development, manufacture, and supply of advanced energetic material products, countermeasures, sensors, and information solutions for the aerospace, defence, security, and safety markets. The company operates primarily through two segments: Countermeasures & Energetics and Sensors & Information. Its Countermeasures & Energetics segment includes precision-engineered energetic devices, propellants, air and naval decoys, and explosive ordnance disposal products. The Sensors & Information segment focuses on electronic countermeasures, biological threat detection equipment, cyber, communications, AI-enabled sensor technologies, and advanced information advantage solutions. Chemring serves government, military, and security agencies globally, with operations spanning the UK, US, Europe, and Asia Pacific. Founded in 1905 and headquartered in Romsey, Hampshire, UK, the company employs approximately 2,700 people. In recent major developments, Chemring completed the acquisition of Landguard Nexus Limited and its subsidiaries in August 2025, a move that strengthens Chemring's Roke Manor business focused on UK sovereign defence, national security, and law enforcement solutions. The acquisition of Landguard, which specializes in tracking devices utilizing iridium, cellular, and RF technologies, enhances Chemring's portfolio in intelligence, surveillance, target acquisition, and reconnaissance (ISTAR) capabilities. In 2024, Chemring increased its investment in expanding energetic material production capacity from £120 million to £200 million and secured a record order book, highlighting strong demand across its product lines. The company continues to pursue strategic growth through organic investment and targeted acquisitions, with a live pipeline for expanding in cyber, information advantage, and US space and missile markets. Chemring also focuses on modernization, automation, and new product development aligned with evolving defence and security customer needs.

Company News

APIChat